跳到內容

骨科

止血的管理和優化

抗纖溶藥物

Intraoperative pharmacotherapeutic blood management strategies in total knee arthroplasty. (開啟新視窗)

Banerjee S, Issa K, Pivec R, McElroy MJ, Khanuja HS, Harwin SF, Mont MA.

來源‎: J Knee Surg 2013;26(6):379-85.

檢索‎: PubMed 23955184

DOI碼‎: 10.1055/s-0033-1353992

https://www.ncbi.nlm.nih.gov/pubmed/23955184 (開啟新視窗)

Tranexamic acid in patients undergoing noncardiac surgery. (開啟新視窗)

Devereaux PJ, Marcucci M, Painter TW, Conen D, Lomivorotov V, Sessler DI, Chan MTV, Borges FK, Martínez-Zapata MJ, Wang CY, Xavier D, Ofori SN, Wang MK, Efremov S, Landoni G, Kleinlugtenbelt YV, Szczeklik W, Schmartz D, Garg AX, Short TG, Wittmann M, Meyhoff CS, Amir M, Torres D, Patel A, Duceppe E, Ruetzler K, Parlow JL, Tandon V, Fleischmann E, Polanczyk CA, Lamy A, Astrakov SV, Rao M, Wu WKK, Bhatt K, de Nadal M, Likhvantsev VV, Paniagua P, Aguado HJ, Whitlock RP, McGillion MH, Prystajecky M, Vincent J, Eikelboom J, Copland I, Balasubramanian K, Turan A, Bangdiwala SI, Stillo D, Gross PL, Cafaro T, Alfonsi P, Roshanov PS, Belley-Côté EP, Spence J, Richards T, VanHelder T, McIntyre W, Guyatt G, Yusuf S, Leslie K; POISE-3 Investigators

來源‎: N Engl J Med. 2022;386(21):1986-97.

檢索‎: PubMed 35363452

DOI碼‎: 10.1056/NEJMoa2201171

https://pubmed.ncbi.nlm.nih.gov/35363452/ (開啟新視窗)

Repeat-dose intravenous tranexamic acid further decreases blood loss in total knee arthroplasty. (開啟新視窗)

Iwai T, Tsuji S, Tomita T, Sugamoto K, Hideki Y, Hamada M.

來源‎: Int Orthop 2013;37(3):441-5.

檢索‎: PubMed 23371424

DOI碼‎: 10.1007/s00264-013-1787-7

https://www.ncbi.nlm.nih.gov/pubmed/23371424 (開啟新視窗)

The efficacy of combined use of intraarticular and intravenous tranexamic acid on reducing blood loss and transfusion rate in total knee arthroplasty. (開啟新視窗)

Lin SY, Chen CH, Fu YC, Huang PJ, Chang JK, Huang HT.

來源‎: J Arthroplasty 2015;30(5):776-80.

檢索‎: PubMed 25534864

DOI碼‎: 10.1016/j.arth.2014.12.001

https://www.ncbi.nlm.nih.gov/pubmed/25534864 (開啟新視窗)

重組活化凝血因子VII(rFVIIa)

局部止血藥

A comprehensive review of topical hemostatic agents: efficacy and recommendations for use. (開啟新視窗)

Achneck HE, Sileshi B, Jamiolkowski RM, Albala DM, Shapiro ML, Lawson JH.

來源‎: Ann Surg 2010;251(2):217-28.

檢索‎: PubMed 20010084

DOI碼‎: 10.1097/SLA.0b013e3181c3bcca

https://www.ncbi.nlm.nih.gov/pubmed/20010084 (開啟新視窗)

Hemostatic techniques reduce hospital stay following multilevel posterior cervical spine surgery. (開啟新視窗)

Cho SK, Yi JS, Park MS, Hu G, Zebala LP, Pahys JM, Kang MM, Lee DH, Riew KD.

來源‎: J Bone Joint Surg Am 2012;94(21):1952-8.

檢索‎: PubMed 23138237

DOI碼‎: 10.2106/JBJS.K.00632

https://www.ncbi.nlm.nih.gov/pubmed/23138237 (開啟新視窗)

The efficacy of bone wax in reduction of perioperative blood loss in total hip arthroplasty via direct anterior approach: a prospective randomized clinical trial. (開啟新視窗)

Mortazavi SMJ, Razzaghof M, Ghadimi E, Seyedtabaei SMM, Vahedian Ardakani M, Moharrami A

來源‎: J Bone Joint Surg Am. 2022;104(20):1805-13.

檢索‎: PubMed 35984033

DOI碼‎: 10.2106/JBJS.22.00376

https://pubmed.ncbi.nlm.nih.gov/35984033/ (開啟新視窗)

Use of a fibrin sealant within a blood-saving protocol in patients undergoing revision hip arthroplasty: effects on post-operative blood transfusion and healthcare-related cost analysis. (開啟新視窗)

Scardino M, Martorelli F, D'Amato T, Fenocchio G, Simili V, Grappiolo G, Di Matteo B, Kon E, Lagioia M

來源‎: Int Orthop 2019;43(12):2707-14.

檢索‎: PubMed 30671601

DOI碼‎: 10.1007/s00264-019-04291-4

https://www.ncbi.nlm.nih.gov/pubmed/30671601 (開啟新視窗)